The binding of thyroid transcription factor-1 and hepatocyte paraffin 1 to mitochondrial proteins in hepatocytes: A molecular and immunoelectron microscopic study

American Journal of Clinical Pathology

Volumn 125, Issue 5, 2006, Pages 722-726

  Pang, Yijun ^a,b   Von Turkovich, Michele ^a   Wu, Hui ^a   Mitchell, Jeannette ^a   Mount, Sharon ^a   Taatjes, Douglas ^a   Cooper, Kumarasen ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Hep Par 1; Hepatocellular carcinoma; Hepatocyte paraffin 1; Hepatocytes; Immunoelectron microscopy; Mitochondria; Thyroid transcription factor 1; TTF 1 (8G7G3 1); Western blot

Indexed keywords

HEPATOCYTE PARAFFIN 1; MITOCHONDRIAL PROTEIN; MONOCLONAL ANTIBODY; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; KIDNEY TUBULE; LIVER CELL; LIVER CELL CARCINOMA; MITOCHONDRION; PRIORITY JOURNAL; THYROID GLAND; WESTERN BLOTTING;

EID: 33646263579     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/EBCB6H54K1N2P9QL     Document Type: Article

References (24)

1. Wennerberg AE, Alesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol. 1993;143:1050-1054.
2. Wieczorek TJ, Pinkus JL, Glickman JN, et al. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol. 2002;118:911-921.
3. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol. 1997;10:686-692.
4. Fan Z, van de Rijn M, Montgomery K, et al. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16:137-144.
5. Chu PG, Jiang Z, Weiss L. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol. 2003;27:952-959.
6. Lau SK, Desrochers MJ, Luthringer DJ. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Mod Pathol. 2002;15:538-542.
7. Bohinski RJ, Di Lauro R, Whitsett JA. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol. 1994:14:5671-5681.
8. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high through-put tissue microarray and immunohistochemistry study. Hum Pathol. 2003;34:597-604.
9. Hecht JL, Pinkus JL, Weinstein LJ, et al. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol. 2001;116:483-488.
10. Wu M, Wang B, Gil J, et al. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol. 2003;199:696-702.
11. Nakamura N, Miyagi E, Murata S, et al. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissue. Mod Pathol. 2002;16:1058-1066.
12. Bejarano PA, Mousavi F. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity. Arch Pathol Lab Med. 2002;127:193-195.
13. Roth J, Bendayan M, Orci L. Ultrastructural localization of intracellular antigens by the use of protein A-gold complex. J Histochem Cytochem. 1978;26:1074-1081.
14. Mount SL, Taatjes DJ, VonTurkovich M, et al. Diagnostic immunoelectron microscopy in surgical pathology: assessment of various tissue fixation and processing protocols. Ultrastruct Pathol. 1993;17:547-556.
15. Mount SL, Taatjes DJ, Trainer TD, et al. Localization of anti-Leu-MI (CD15) binding sites in Hodgkin's disease by immunoelectron microscopic examination. Am J Clin Pathol. 1994;101:140-148.
16. Mount SL, Taatjes DJ. Neuroendocrine carcinoma of the skin (Merkel cell carcinoma): an immunoelectron-microscopic case study. Am J Dermatopathol. 1994;16:60-65.
17. Mount SL, Weaver DL, Taatjes DJ, et al. von Hippel-Lindau disease presenting as pancreatic neuroendocrine tumour. Virchows Arch. 1995;426:523-528.
18. Taatjes DJ, Arendash-Durand B, von Turkovich M, et al. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy. Arch Pathol Lab Med. 1992;117:264-268.
19. Taatjes DJ, Pang Y, von Turkovich M, et al. Ultrastructural localization of diagnostically relevant melanoma-specific antibodies by immunoelectron microscopy. J Histotechnol. 2003;26:263-266.
20. Mount SL, Dickerman JD, Taatjes DJ. Extrarenal Wilms' tumor: an ultrastructural and immunoelectron microscopic case report. Ultrastruct Pathol. 1996;20:155-165.
21. Peterson RS, Clevidence DE, Ye H, et al. Hepatocyte nuclear factor-3a promoter regulation involves recognition by cell-specific factors, thyroid transcription factor-1 and autoactivation. Cell Growth Differ. 1997;8:68-82.
22. Damante G, Di Lauro R. Several regions of antennapedia and thyroid transcription factor 1 homeodomains contribute to DNA binding specificity. Proc Natl Acad Sci USA. 1991;88:5388-5392.
23. Bingle C. Thyroid transcription factor-1. Int J Biochem Cell Biol. 1997;29:1471-1473.
24. Puppin C, D'Elia AV, Pellizzari L, et al. Thyroid-specific transcription factors control Hex promoter activity. Nucleic Acids Res. 2003;31:1845-1852.